NL-OMON40472已完成不适用
Evaluation of a new vancomycin dosage guideline in pediatric oncology patients. - Vancomycin dosing in pediatric oncology patients.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •- Age 1 - 18 years
- •- Treatment with vancomycin i.v. for a clinically suspected or proven (catheter-related) infection
- •if age < 12 year: starting dose of 90 mg/kg/day (± 10%) divided in 4 doses, if age 12-18 year: starting dose of 60 mg/kg/day (± 10%) divided in 4 doses
- •- Diagnosed with a malignant disease for which treatment with chemotherapy is started
- •- Signed informed consent
排除标准
- •- Inability to monitor drug levels during treatment
- •- Kidney function test (serum creatinine): 2x ULN (upper limit of normal)
研究者
相似试验
已完成
不适用
Evaluation of a new Dutch vancomycin dosage guideline in preterm and term neonates.Antibiotic treatment10004018NL-OMON42496Academisch Medisch Centrum30
招募中
2 期
Optimizing vancomycin dosing in septic patientsIRCT20100228003449N24Tehran University of Medical Sciences40
招募中
不适用
Development of a new dosing strategy of vancomycin using target concentration-controlled infusioKCT0003462Asan Medical Center386
招募中
2 期
Comparison of the different doses of vancomycin on plasma concentration of the drug in patients hospitalized in ICOsteomyelitisIRCT201710109014N194Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences70
尚未招募
不适用
Optimalisation of vancomycine dosage regimens in pediatric patientsblood poisoningserious infection10004018NL-OMON30777Academisch Medisch Centrum200